RavenQuest BioMed Inc.
RVVQF
$0.00
$0.000.00%
| 07/31/2019 | 04/30/2019 | 01/31/2019 | 10/31/2018 | 07/31/2018 | |
|---|---|---|---|---|---|
| Revenue | 534.40K | 490.40K | 225.20K | -108.10K | 131.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 534.40K | 490.40K | 225.20K | -108.10K | 131.80K |
| Cost of Revenue | 200.90K | 588.90K | -349.20K | 33.50K | 11.40K |
| Gross Profit | 333.50K | -98.50K | 574.50K | -141.60K | 120.40K |
| SG&A Expenses | 1.83M | 1.29M | 1.80M | 3.19M | 1.98M |
| Depreciation & Amortization | 605.20K | 361.10K | 578.80K | 1.41M | 28.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.64M | 2.30M | 2.03M | 4.63M | 2.02M |
| Operating Income | -2.10M | -1.81M | -1.80M | -4.74M | -1.89M |
| Income Before Tax | -2.35M | -2.41M | -2.40M | -17.96M | -2.44M |
| Income Tax Expenses | -- | -- | -- | -443.60K | -- |
| Earnings from Continuing Operations | -2.35M | -2.41M | -2.40M | -17.52M | -2.44M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.35M | -2.41M | -2.40M | -17.52M | -2.44M |
| EBIT | -2.10M | -1.81M | -1.80M | -4.74M | -1.89M |
| EBITDA | -1.50M | -1.45M | -1.23M | -3.33M | -1.86M |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.16 | -0.03 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.05 | -0.02 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.16 | -0.03 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.05 | -0.02 |
| Average Basic Shares Outstanding | 119.65M | 115.09M | 112.86M | 109.32M | 96.22M |
| Average Diluted Shares Outstanding | 119.65M | 115.09M | 112.86M | 109.32M | 96.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
